Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 866.00
-28.60 (-3.20%)
Aug 14, 2025, 12:31 PM IDT
Achilles Therapeutics Market Cap
Epitomee Medical has a market cap or net worth of 266.66 million as of August 14, 2025. Its market cap has increased by 171.69% in one year.
Market Cap
266.66M
Enterprise Value
202.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$866.00
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 266.66M, a decrease of -77.88%. That is a compound annual growth rate of -33.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 266.66M | -1.53% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 64.51B |
| Danel (Adir Yeoshua) | 2.56B |
| Kamada | 1.44B |
| Bait Bakfar | 1.05B |
| SofWave Medical | 992.61M |
| BrainsWay | 772.64M |
| Novolog (Pharm-Up 1966) | 709.61M |
| Ilex Medical | 675.99M |